AlanW.HeldmanMD

Cardiology • Miami, FL

Adult Congenital Heart Disease, Interventional Cardiology

Founder - Modern Cardiovascular Technologies

Join to view full profile

Dr. Heldman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heldman's full profile

Already have an account?

Office
1295 NW 14th Street
Suite A
Miami, FL 33136
Phone+1 305-243-1900

Fax+1 305-243-1901

Education & Training

Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1991 - 1995
Johns Hopkins UniversityResidency, Internal Medicine, 1988 - 1991
University of Alabama School of MedicineClass of 1988

Certifications & Licensure

MD State Medical License 1993 - 2022
FL State Medical License 2007 - 2020

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
America's Top Doctors Castle Connolly, 2010-2011
Super Doctor SuperDoctors.com

Clinical Trials

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Start of enrollment: 2007 Nov 01
Terminated
Phase 1, Phase 2
The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT) Start of enrollment: 2008 Aug 01
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

71 citations
New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral, transapical, transaortic, and surgical approaches.
Tanyanan Tanawuttiwat, Brian P. O'Neill, Mauricio G. Cohen, Orawee Chinthakanan, Alan W. Heldman
Journal of the American College of Cardiology. 2013-03-01
884 citations
Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The...
Joshua M. Hare, Joel E. Fishman, Gary Gerstenblith, Darcy L. Velazquez, Juan P. Zambrano
JAMA. 2012-12-12
128 citations
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea, Angela C. Rieger, Darcy L. DiFede, Jill El-Khorazaty, Makoto Natsumeda
Circulation Research. 2017-11-10

Press Mentions

Health News - Two New Miller School Studies Show How Stem Cell Injections Improve Heart StructureFebruary 10th, 2016

Grant Support

Animal CoreNational Heart, Lung, And Blood Institute2007–2009
Animal CoreNational Heart, Lung, And Blood Institute2005–2006
Women'S Angiographic Vitamins And Estroogens TrialNational Center For Research Resources2000